2 Healthcare Technology Stocks for a Digital Health Boom

Impact · against what's priced in

The article provides general thematic support for healthcare technology but offers no concrete catalyst to bridge the valuation gap for GMED. While the sector outlook is positive, it fails to provide evidence that GMED can maintain mid-teens growth, which the market currently rejects.

GMED+0.00

Already priced in

The price assumes

A sustained 10% U.S. spine growth rate that merely offsets the drag from other segments to hit the 3% blended path.

The projected 7.6% increase in healthcare technology budgets supports a generally favorable environment, but this aligns with the market's current baseline assumption of low single-digit blended growth for the company.

What GMED's price assumes · Sep 10

• ai
• GMED
• STE
• automation
• digital transformation
• healthcare innovation
• healthcare tech
• healthtech
• medical devices
• robotic surgery

Search tags